In general, our findings reveal that POLE2 overexpression inhibits ferroptosis of human gastric cancer cells through activating the NRF2/GPX4 pathway and provide a theoretical basis of molecular therapy for gastric cancer through inhibiting POLE2. The gene discussed is GPX4; the disease is gastric cancer.